Cognetivity Neurosciences Signs Commercial Deal With Dubai Health Authority

Cognetivity Neurosciences (CSE: CGN) continues to expand the deployment of its Integrated Cognitive Assessment, or ICA. The firm this morning announced that it has reached a commercial arrangement with the Dubai Health Authority.

The commercial agreement follows a similar deal entered into last month by the company. That transaction saw the firm enter an agreement with the Emirates Health Services, whom is the main federal provider of healthcare within the UAE. The arrangement will see the deployment of the firms ICA across the country.

In terms of the Dubai Health Authority, the commercial agreement will see the firms technology implemented at the busiest dementia clinics within Dubai. The rollout will see the health authority also explore the potential of screening the entire population with the tool as a means of detecting the signs of dementia early in its onset.

The authority is known in the region for being proactive with its healthcare processes, having been one of the first authorities to implement telehealth tech solutions. The offering from Cognetivity will be used by the authority for the early diagnosis of mild cognitive impairment and Alzheimer’s Disease.

“It’s particularly exciting that this project lays the groundwork for even larger, population-wide screening initiatives. With its relatively small size and tech-centred ethos, the UAE is the perfect environment for us to trial such programmes, which we believe we can one day bring to countries as large as the US and China,” stated CEO Sina Habibi on the announcement.

Cognetivity Neurosciences last traded at $0.53 on the CSE.


FULL DISCLOSURE: Cognetivity Neurosciences Ltd is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Cognetivity Neurosciences Ltd on The Deep Dive, with The Deep Dive having full editorial control. We may buy or sell securities in the company at any time. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

The Russell Will Lead the Next Market Crash!? | John Feneck

The Global Conflict Has Already Started | Bryan Cunningham

Silver Still At 90:1, What If It Snaps Back To 15:1? | Glenn Jessome – Silver Tiger

Recommended

ESGold Secures $9 Million In Non-Dilutive Funding From Ocean Partners

Altamira Gold Encounters Porphyritic Intrusive Rocks In Initial Scout Drilling At Regional Targets

Related News

Cognetivity’s Assessment Tool To Be Deployed At KetamineOne Clinics Across North America

Cognetivity Neurosciences (CSE: CGN) will soon see its cognitive assessment tool for the early detection...

Wednesday, September 1, 2021, 08:22:59 AM

Cognetivity: Tech For Brain Health Screening – The Daily Dive

Joining us again on The Daily Dive is Dr. Thomas Sawyer, COO of Cognetivity Neurosciences...

Tuesday, June 21, 2022, 01:30:00 PM

Cognetivity: Utilizing AI for Early Alzheimer’s Intervention

Sina Habibi, Co-founder & CEO of Cognetivity Neurosciences (CSE: CGN) sits down with us today...

Wednesday, June 14, 2023, 01:30:00 PM

Cognetivity Neurosciences Files Patent For System Capable Of Early Detection Of Alzheimer’s Disease

Cognetivity Neurosciences (CSE: CGN) this morning announced that it has filed for a key new...

Tuesday, June 8, 2021, 10:08:19 AM

Cognetivity’s Brain Health Monitoring App – The Daily Dive

On this Daily Dive episode, Cassandra talks to Dr. Sina Habibi, CEO of Cognetivity Neurosciences...

Friday, November 19, 2021, 03:28:00 PM